Dermatomyositis and polymyositis: from immunopathology to immunotherapy (immunobiologics)-Reference-Cited by-同舟云学术

Dermatomyositis and polymyositis: from immunopathology to immunotherapy (immunobiologics)

Published:2013-01 Issue:1 Volume:53 Page:101-110
ISSN:2255-5021
Container-title:Revista Brasileira de Reumatologia (English Edition)
language:en
Short-container-title:Revista Brasileira de Reumatologia (English Edition)

Author:

Shinjo Samuel Katsuyuki,de Souza Fernando Henrique Carlos,de Moraes Julio Cesar Bertacini

Publisher

Elsevier BV

Reference63 articles.

1. Increased expression of interleukin 1alpha and MHC Class I in muscle tissue of patients with chronic, inactive polymyositis and dermatomyositis;Nyberg;J Rheumatol,2000

2. Differential expression of perforin in muscleinfiltrating T cells in polymyositis and dermatomyositis;Goebels;J Clin Invest,1996

3. Microvascular changes in early and advanced dermatomyositis: a quantitative study;Emslie-Smith;Ann Neurol,1990

4. Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies;Engel;Hum Pathol,1986

5. Characterization of mononuclear exudates in idiopathic inflammatory myopathies;Botet;Virchows Arch A Pathol Anat Histopathol,1988

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic Inflammatory Disorders, Immunosuppressive Treatment and Increase Risk of Head and Neck Cancers—A Narrative Review of Potential Physiopathological and Biological Mechanisms;Cells;2023-09-01

2. Identification of hub biomarkers and immune cell infiltration characteristics of polymyositis by bioinformatics analysis;Frontiers in Immunology;2022-09-26

3. A novel model of dermatomyositis induced by membrane antigen and calciphylaxis in rats;Biomedical Reports;2022-02-24

4. Response to cyclophosphamide and rituximab therapy in idiopathic inflammatory myopathies: A single center experience;The Egyptian Rheumatologist;2021-06

5. Absolute reduction of regulatory T cells and regulatory effect of short-term and low-dose IL-2 in polymyositis or dermatomyositis;International Immunopharmacology;2019-12